4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000899243-19-014470
Director acquired 2,057 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
TARNOW MICHAEL M · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-21 | Exercise or conversion : show line 1 in the form | +2,057 | $3.21 | $6,603 | 64,569 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-05-21 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −2,057 | 0 | D |
Loading xslF345X03/doc4.xml…